Tweetovi

Blokirali ste korisnika/cu @translationalpk

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @translationalpk

  1. proslijedio/la je Tweet
    2. sij

    Taking delivery of two LC-MS/MS was a fantastic way to end 2019 . These will totally transform bioanalytical capability in Nigeria and in the region. Big thank you to collaborators .

    Poništi
  2. proslijedio/la je Tweet
    13. stu 2019.

    Group activities for Day 3 ongoing.

    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet
    12. stu 2019.

    ONGOING: One-week (11-15 Nov 2019) training course on popPK modeling . Participants from Ghana, Nigeria & South Africa being taught by Prof. Leon Aaron & Dr Kay Ogungbenro of , and Dr Paolo Denti & Mahmoud Abdelwahab of . By PMxAfrica

    Prikaži ovu nit
    Poništi
  4. WCoP 2020 will support eligible young and established scientists with scholarships to cover travel & accommodation expenses. See .

    Poništi
  5. [Upcoming Webinar]: Exploratory & Noncompartmental Analyses of PK/PD Data. Pharmacometrics Africa and partners are excited to announce this live webinar on 4th November 2019 at 3:00 pm GMT. It will be presented by Dr Samer Mouksassi. Register here:

    Poništi
  6. proslijedio/la je Tweet
    9. lis 2019.

    Dolutegravir-based regimen noninferior to an efavirenz 400mg-based reference regimen with regard to viral suppression at week 48. But for patients with 100,000 copies/mL or more at baseline, fewer than expected had viral suppression .

    Poništi
  7. proslijedio/la je Tweet
    28. srp 2019.

    I recommend this e-course for students, researchers and clinicians interested in learning more about pharmacometrics. It is well paced and fun too. In addition, you enjoy the luxury of top-notch experts to guide you through the entire learning process.1

    Prikaži ovu nit
    Poništi
  8. Dolutegravir achieves more rapid virological suppression before delivery compared to efavirenz when initiated in late pregnancy. Regardless of arm, late presentation in pregnancy is associated with poor outcomes despite ART. .

    Poništi
  9. Poništi
  10. Prikaži ovu nit
    Poništi
  11. It was so exciting from start...

    Prikaži ovu nit
    Poništi
  12. Moments from . We're now looking forward to inviting participants to the next course.

    Poništi
  13. proslijedio/la je Tweet
    11. sij 2019.

    A small number of people living with known as “HIV controllers” can control the virus without needing antiretroviral treatment. A new study in explores the factors implicated in the development of HIV among HIV controllers

    Poništi
  14. proslijedio/la je Tweet
    10. sij 2019.

    A study has revealed new genes that help regulate the immune system, and created a map of T cell regulation. This could help scientists develop drugs to activate the system against or in the future.

    Poništi
  15. proslijedio/la je Tweet
    11. sij 2019.

    We need more statisticians to -funded research. Could you help?

    Poništi
  16. proslijedio/la je Tweet

    has endorsed the progressive open publishing position, Plan S, of the European Union.Plan S is an initiative for open access publishing that was launched in September 2018 👉

    Prikaži ovu nit
    Poništi
  17. proslijedio/la je Tweet
    27. stu 2018.

    According to new -supported survey data, may be closer to achieving epidemic control than was previously thought, with most Nigerians who report being on HIV having suppressed their viral replication.

    Poništi
  18. Full text available here: . Many thanks to HIV Research Trust & Novartis Pharma AG for funding that made this work possible, and to our collaborators for access to the Liverpool Bioanalytical Facility.

    Prikaži ovu nit
    Poništi
  19. ...increased from 10% without artemether-lumefantrine (all extensive metabolisers) to 21% with artemether-lumefantrine (14% extensive, 4% intermediate, and 3% poor metabolisers).

    Prikaži ovu nit
    Poništi
  20. No clinically significant changes were observed in key nevirapine PK parameters, the 90% CI falling completely within the 0.80-1.25 no-effect boundaries. However, # of patients with trough plasma nevirapine concentration below the 3,400 ng ml-1 minimum effective concentration..

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·